Cargando…

Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage

Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease with heterogeneous clinical manifestations. A diverse innate and adaptive immune dysregulation is involved in the immunopathogenesis of SLE. The dysregulation of immune-related cells may derive from the intricate interaction...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Chang-Youh, Shen, Chieh-Yu, Liu, Chih-Wei, Hsieh, Song-Chou, Liao, Hsien-Tzung, Li, Ko-Jen, Lu, Cheng-Shiun, Lee, Hui-Ting, Lin, Cheng-Sung, Wu, Cheng-Han, Kuo, Yu-Min, Yu, Chia-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762297/
https://www.ncbi.nlm.nih.gov/pubmed/33291347
http://dx.doi.org/10.3390/biom10121641
_version_ 1783627771849736192
author Tsai, Chang-Youh
Shen, Chieh-Yu
Liu, Chih-Wei
Hsieh, Song-Chou
Liao, Hsien-Tzung
Li, Ko-Jen
Lu, Cheng-Shiun
Lee, Hui-Ting
Lin, Cheng-Sung
Wu, Cheng-Han
Kuo, Yu-Min
Yu, Chia-Li
author_facet Tsai, Chang-Youh
Shen, Chieh-Yu
Liu, Chih-Wei
Hsieh, Song-Chou
Liao, Hsien-Tzung
Li, Ko-Jen
Lu, Cheng-Shiun
Lee, Hui-Ting
Lin, Cheng-Sung
Wu, Cheng-Han
Kuo, Yu-Min
Yu, Chia-Li
author_sort Tsai, Chang-Youh
collection PubMed
description Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease with heterogeneous clinical manifestations. A diverse innate and adaptive immune dysregulation is involved in the immunopathogenesis of SLE. The dysregulation of immune-related cells may derive from the intricate interactions among genetic, epigenetic, environmental, and immunological factors. Of these contributing factors, non-coding RNAs (ncRNAs), including microRNAs (miRNAs, miRs), and long non-coding RNAs (lncRNAs) play critical roles in the post-transcriptional mRNA expression of cytokines, chemokines, and growth factors, which are essential for immune modulation. In the present review, we emphasize the roles of ncRNA expression in the immune-related cells and cell-free plasma, urine, and tissues contributing to the immunopathogenesis and tissue damage in SLE. In addition, the circular RNAs (circRNA) and their post-translational regulation of protein synthesis in SLE are also briefly described. We wish these critical reviews would be useful in the search for biomarkers/biosignatures and novel therapeutic strategies for SLE patients in the future.
format Online
Article
Text
id pubmed-7762297
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77622972020-12-26 Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage Tsai, Chang-Youh Shen, Chieh-Yu Liu, Chih-Wei Hsieh, Song-Chou Liao, Hsien-Tzung Li, Ko-Jen Lu, Cheng-Shiun Lee, Hui-Ting Lin, Cheng-Sung Wu, Cheng-Han Kuo, Yu-Min Yu, Chia-Li Biomolecules Review Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease with heterogeneous clinical manifestations. A diverse innate and adaptive immune dysregulation is involved in the immunopathogenesis of SLE. The dysregulation of immune-related cells may derive from the intricate interactions among genetic, epigenetic, environmental, and immunological factors. Of these contributing factors, non-coding RNAs (ncRNAs), including microRNAs (miRNAs, miRs), and long non-coding RNAs (lncRNAs) play critical roles in the post-transcriptional mRNA expression of cytokines, chemokines, and growth factors, which are essential for immune modulation. In the present review, we emphasize the roles of ncRNA expression in the immune-related cells and cell-free plasma, urine, and tissues contributing to the immunopathogenesis and tissue damage in SLE. In addition, the circular RNAs (circRNA) and their post-translational regulation of protein synthesis in SLE are also briefly described. We wish these critical reviews would be useful in the search for biomarkers/biosignatures and novel therapeutic strategies for SLE patients in the future. MDPI 2020-12-06 /pmc/articles/PMC7762297/ /pubmed/33291347 http://dx.doi.org/10.3390/biom10121641 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tsai, Chang-Youh
Shen, Chieh-Yu
Liu, Chih-Wei
Hsieh, Song-Chou
Liao, Hsien-Tzung
Li, Ko-Jen
Lu, Cheng-Shiun
Lee, Hui-Ting
Lin, Cheng-Sung
Wu, Cheng-Han
Kuo, Yu-Min
Yu, Chia-Li
Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage
title Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage
title_full Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage
title_fullStr Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage
title_full_unstemmed Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage
title_short Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage
title_sort aberrant non-coding rna expression in patients with systemic lupus erythematosus: consequences for immune dysfunctions and tissue damage
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762297/
https://www.ncbi.nlm.nih.gov/pubmed/33291347
http://dx.doi.org/10.3390/biom10121641
work_keys_str_mv AT tsaichangyouh aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage
AT shenchiehyu aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage
AT liuchihwei aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage
AT hsiehsongchou aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage
AT liaohsientzung aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage
AT likojen aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage
AT luchengshiun aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage
AT leehuiting aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage
AT linchengsung aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage
AT wuchenghan aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage
AT kuoyumin aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage
AT yuchiali aberrantnoncodingrnaexpressioninpatientswithsystemiclupuserythematosusconsequencesforimmunedysfunctionsandtissuedamage